Lipid-lowering therapy is associated with lower mortality in heart failure patients: Insights from Swedish national registries data from 2006 to 2022

Back

ESC2025 Premium Access

Lipid-lowering therapy is associated with lower mortality in heart failure patients: Insights from Swedish national registries data from 2006 to 2022

Session: Prognosis and heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor A. Berg (Gothenburg, SE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Anton Berg

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

0 follower

6 more presentations in this session

Cardiorenal outcomes and all-cause mortality in patients with comorbid heart failure and chronic kidney disease across three countries (The CaRe Study)

Speaker: Associate Professor G. Savarese (Stockholm, SE)

Short-term exposure to low and high temperatures and mortality in heart failure patients: a nationwide study in Sweden

Speaker: Professor S. Agewall (Stockholm, SE)

Prognostic impact of the INTERMACS class and advanced HF according to 4 HFA-ESC 2018 criteria: Insights From the HELP-HF Registry

Speaker: Doctor M. De Carli (Milan, IT)

Right ventricular-pulmonary artery coupling in acute heart failure: prognostic significance and implications for intensive care management

Speaker: Miss A. Caputo (Rome, IT)

Risk of adverse events in takotsubo syndrome compared to heart failure: observations from a global federated network

Speaker: Doctor E. Tartaglia (Liverpool, GB)

Access the full session

Prognosis and heart failure

Speakers: Doctor A. Berg, Associate Professor G. Savarese, Professor S. Agewall, Doctor M. De Carli, Miss A. Caputo...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources